Advances in liposomes in anticancer drug delivery systems
DOI:
https://doi.org/10.54097/dv3hqt50Keywords:
Tumor, liposome, drug delivery.Abstract
The tumor is a complex and severe physical illness with a mass of abnormal cells, which affects a significant number of individuals across the globe. This illness can have a profound influence on those who suffer from it, both physically and mentally, and its appearing positions and symptoms are various and mutable. Despite the challenges it presents, scientists work on treatments and medicines to improve symptoms. One of the popular treatments is drug delivery, which is the process of releasing a drug inside the human body. Nanotechnology is promising in this field because of the demand for dedicated release. As one of the nanoparticles, liposomes present an excellent performance and potential future in drug delivery. The literature review attempts to show liposome structure, features, and significant applications by considering recent research based on authoritative theories. Through the review of previous studies, it could be proposed that liposomes earn significant progress in labs but still need further exploration to make advances in clinical applications.
Downloads
References
[1] Cairns J. Cancer. W.H. Freeman. 1978.
[2] Cooper G.M. The development and causes of cancer. NIH. GOV; Sinauer Associates. 2020.
[3] Ferlay J., Colombet M., Seromata I., et al. Cancer statistics for the year 2020: An overview. International Journal of Cancer, 2021, 149 (4) 778 - 789. DOI: https://doi.org/10.1002/ijc.33588
[4] National Cancer Institute. Possible side effects of everolimus. National Cancer Institute. 2024.
[5] Nsairat H., Khater D., Sayed U., et al. Liposomes: structure, composition, types, and Clinical Applications. Heliyon, 2022, 8 (5): e09394. DOI: https://doi.org/10.1016/j.heliyon.2022.e09394
[6] Li J., Wang X., Zhang T., et al. A review on phospholipids and their main applications in drug delivery systems. Asian Journal of Pharmaceutical Sciences, 2015, 10 (2): 81 - 98. DOI: https://doi.org/10.1016/j.ajps.2014.09.004
[7] Akinc A., Maier M.A., Manoharan M., et al. The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs. Nature Nanotechnology, 2019, 14 (12): 1084 - 1087. DOI: https://doi.org/10.1038/s41565-019-0591-y
[8] Allen T.M., Hansen C.J., Martin F.F., et al. Liposomes containing synthetic lipid derivatives of poly (ethylene glycol) show prolonged circulation half-lives in vivo. Biochimica et Biophysica Acta Bio membranes, 1991, 1066 (1): 29 - 36. DOI: https://doi.org/10.1016/0005-2736(91)90246-5
[9] Li J., Wang X., Zhang T., et al. A review on phospholipids and their main applications in drug delivery systems. Asian Journal of Pharmaceutical Sciences, 2015, 10 (2): 81 - 98. DOI: https://doi.org/10.1016/j.ajps.2014.09.004
[10] Akhter S., Zaki Ahmad M., Singh A., et al. Cancer targeted metallic nanoparticle: targeting overview, recent advancement and toxicity concern. Current Pharmaceutical Design, 2011, 17 (18): 1834 - 1850. DOI: https://doi.org/10.2174/138161211796391001
[11] Moosavian S.A., Bianconi V., Pirro M., et al. Challenges and pitfalls in the development of liposomal delivery systems for cancer therapy. Seminars in Cancer Biology, 2021, 69: 337 - 348. DOI: https://doi.org/10.1016/j.semcancer.2019.09.025
[12] Yatvin M.B., Kreutz W., Horwitz B., et al. Induced drug release from lipid vesicles in serum by pH change. Biophysics of Structure and Mechanism, 1980. 6 (3): 233 – 234. DOI: https://doi.org/10.1007/BF00537296
[13] Paliwal S.R., Paliwal R., Agrawal G.P., et al. Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin. Journal of liposome research, 2016, 26(4): 276-287. DOI: https://doi.org/10.3109/08982104.2015.1117489
[14] Sercombe L., Veerati T., Moheimani F., et al. Advances and challenges of liposome assisted drug delivery—Frontiers in Pharmacology, 2015, 6 (286). DOI: https://doi.org/10.3389/fphar.2015.00286
[15] Saraf S., Jain A., Tiwari A., Verma A., et al. Advances in liposomal drug delivery to cancer: an overview. Journal of Drug Delivery Science and Technology, 2020, 56, 101549. DOI: https://doi.org/10.1016/j.jddst.2020.101549
[16] Zhang H., Gong W., Wang Z.Y., et al. Preparation, characterization, and pharmacodynamics of thermosensitive liposomes containing docetaxel. Journal of Pharmaceutical Sciences, 2014, 103 (7): 2177 – 2183. DOI: https://doi.org/10.1002/jps.24019
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Highlights in Science, Engineering and Technology
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
